British Journal of Clinical Pharmacology · 1986 · 12 citations · 5 references
PharmacyPharmacokineticsPharmacologyDrug ClearancePharmacokinetic ModelingPharmacokinetic-pharmacodynamic ModelingDrug DispositionDrug Half-lifeHalf-life EstimationLinear PharmacokineticsMultiple-dose PharmacokineticsDrug Elimination Half-lifeDrug Half-life EstimationMaximum Observed ConcentrationMexiletine TherapyPharmacokinetic ParametersPharmacokinetic Study DesignRepeated-dose Pharmacokinetics
In 12 healthy volunteers who received orally 100, 200, 300, 400 and 600 mg mexiletine at weekly intervals, the maximum plasma concentration of mexiletine and AUC increased linearly with the dose of mexiletine. Between doses there were no significant differences in the values for clearance and volume of distribution of mexiletine but there were for plasma elimination half-life. These results indicate that the kinetics of mexiletine are linear.
5
SERUM-PHENYTOIN LEVELS IN MANAGEMENT OF EPILEPSY
Alan Richens · The Lancet · 1975 · 188 citations
The clinical pharmacology of mexiletine.
N P Campbell, J.G. Kelly, A A Adgey et al. · British Journal of Clinical Pharmacology · 1978 · 129 citations · Full text
Absorption, distribution and elimination of mexiletine.
Prescott Lf, A. Pottage, Clements Ja · PubMed · 1977 · 119 citations
The distribution, metabolism and excretion of mexiletine in man.
Beckett Ah, Chidomere Ec · PubMed · 1977 · 61 citations